Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

7.6K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.6K
Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Cancer02:18

Cancer

49.1K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
49.1K
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

12.4K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.4K
Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

11.7K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral Lysozyme Attenuates Neuroinflammation and Brain Injury After Traumatic Brain Injury Through Gut Microbiota-Dependent Reprogramming of Tryptophan Metabolism.

CNS neuroscience & therapeutics·2026
Same author

Clinical Prognostic Modeling and Paired Blood-CSF Metabolomic Profiling for Outcome Prediction in Isolated Moderate-to-Severe Traumatic Brain Injury: Implications for Neurocritical Care Management.

Journal of clinical medicine·2026
Same author

How do I do it? Laparoscopic extraperitoneal reverse puncture technique for distal catheter placement in ventriculoperitoneal shunting.

Acta neurochirurgica·2026
Same author

Inhibition of Astrocytic JMJD3 Attenuates Neuroinflammation-Mediated Blood-Brain Barrier Disruption and Improves Functional Recovery After Intracerebral Hemorrhage in Mice.

Brain sciences·2026
Same author

Factors associated with progression and sex-specific patterns in chronic subdural hematoma: a single-centre retrospective study.

Frontiers in neurology·2025
Same author

Prevalence and Risk Factors for Augmented Renal Clearance in Neurocritical Ill Patients.

Journal of clinical laboratory analysis·2025

Related Experiment Video

Updated: Aug 15, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.6K

CircNRIP1: An emerging star in multiple cancers.

Zhuoying Du1

  • 1College of Basic Medical Science, China Three Gorges University, Yichang 443002, China.

Pathology, Research and Practice
|December 31, 2022
PubMed
Summary
This summary is machine-generated.

Circular RNAs (circRNAs) are stable molecules implicated in disease. Circular RNA nuclear receptor interacting protein 1 (circNRIP1) is linked to various cancers and regulates key signaling pathways, showing diagnostic and therapeutic potential.

Keywords:
BiomarkerCancerCircNRIP1Circular RNATumor progression

More Related Videos

Identification of Circular RNAs using RNA Sequencing
08:25

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

12.3K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Related Experiment Videos

Last Updated: Aug 15, 2025

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions
10:27

In Silico Identification and Characterization of circRNAs During Host-Pathogen Interactions

Published on: October 21, 2022

1.6K
Identification of Circular RNAs using RNA Sequencing
08:25

Identification of Circular RNAs using RNA Sequencing

Published on: November 14, 2019

12.3K
Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.7K

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Circular RNAs (circRNAs) are novel non-coding RNAs with a unique closed-loop structure.
  • These molecules are highly stable and prevalent in the eukaryotic cytoplasm.
  • Emerging evidence highlights the significant role of circRNAs in diverse disease pathologies.

Purpose of the Study:

  • To review the biological functions of circNRIP1 in carcinogenesis.
  • To elucidate the target molecular mechanisms of circNRIP1.
  • To explore the clinical potential of circNRIP1 in cancer diagnosis and treatment.

Main Methods:

  • Literature review of studies on circNRIP1 and cancer.
  • Analysis of circNRIP1's role in regulating signaling pathways (ERK1/2, PI3K/AKT, AKT/mTOR).
  • Synthesis of current research on circNRIP1's involvement in various cancer types.

Main Results:

  • Circular RNA nuclear receptor interacting protein 1 (circNRIP1) is associated with cervical carcinoma, colorectal cancer, esophageal squamous cell carcinoma, gastric cancer, nasopharyngeal carcinoma, non-small cell lung cancer, osteosarcoma, ovarian cancer, and papillary thyroid carcinoma.
  • CircNRIP1 influences the activity of critical signaling pathways including ERK1/2, PI3K/AKT, and AKT/mTOR.
  • These regulatory functions suggest a role for circNRIP1 in cancer development.

Conclusions:

  • CircNRIP1 is a significant factor in the pathogenesis of multiple cancers.
  • Understanding circNRIP1's molecular mechanisms offers insights into cancer biology.
  • CircNRIP1 holds promise as a biomarker for cancer diagnosis and a therapeutic target.